The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder.

Ethan D BorreEvan MyersMarianne Hamilton LopezJoanne KurtzbergBeth H ShazJesse TroyGillian Sanders Schmidler

Published in: PloS one (2023)

A modestly effective intervention designed to improve adaptive behavior in autism can be cost-effective under certain circumstances. Intervention cost and efficacy most affected the cost-effectiveness results and should be targeted to increase economic efficiency.

Keyphrases

cord blood
randomized controlled trial
autism spectrum disorder
intellectual disability
risk assessment
human health
life cycle